Cold-adapted influenza vaccines

Current Opinion in Pediatrics

Volumn 14, Issue 1, 2002, Pages 95-98

  Bradshaw, John ^a   Wright, Peter F ^a  

^a D 7235 MCW ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

COLD ACCLIMATIZATION; DRUG EFFICACY; DRUG SAFETY; FEVER; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; NOSE CONGESTION; PRIORITY JOURNAL; REVIEW; RHINORRHEA;

ADMINISTRATION, INTRANASAL; CHILD; CLINICAL TRIALS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINES, ATTENUATED;

EID: 0036186816     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200202000-00017     Document Type: Review

References (26)

1. Prevention and control of influenza
2. Serious morbidity and mortality associated with influenza epidemics
3. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children
4. Influenza virus infections in infants
5. Safety and immunogenicity of live attenuated cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in infants and children
6. Live attenuated influenza vaccines in young seronegative children. International Symposium on Influenza Immunization (II), Develop
7. Comparison of influenza B/Hong Kong virus infection among infants, children, and young adults
8. Prevention, diagnosis, and treatment of influenza: Current and future options
9. Immunity to influenza A virus infection in young children: A comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine
10. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection
11. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
12. Correlates of immune protection induced by live, attenuated, cold adapted, trivalent, intranasal influenza virus vaccine
13. Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia
14. Temperature-sensitive mutants of influenza virus: I. Behavior in tissue culture and in experimental animals
15. Temperature-sensitive mutants of influenza virus II: Attenuation of ts recombinants for man
16. The development of live attenuated cold-adapted influenza virus vaccine for humans
17. Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines
18. Pilot studies on recombinant cold-adapted live type A and B influenza virus vaccines
19. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease
20. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985-1990: The pediatric experience
21. Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects
22. Influenza in children: Epidemiology, immunity, and vaccines
23. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children
24. Evaluation of live attenuated influenza vaccines in children 6-18 months of age: Safety, immunogenicity, and efficacy
25. The Tecumseh Study and respiratory illness: IX. Occurrence of influenza in the community, 1966-1971
26. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines